Volume 11, Issue 2, Pages (June 2016)

Slides:



Advertisements
Similar presentations
Advances in shaking technologies Wolf Klöckner, Jochen Büchs Trends in Biotechnology Volume 30, Issue 6, Pages (June 2012) DOI: /j.tibtech
Advertisements

2015 Alzheimer's disease facts and figures Alzheimer's & Dementia: The Journal of the Alzheimer's Association Volume 11, Issue 3, Pages (March.
Global Burden of Atrial Fibrillation in Developed and Developing Nations Sumeet S. Chugh, Gregory A. Roth, Richard F. Gillum, George A. Mensah Global Heart.
Date of download: 6/3/2016 From: Elevated Plasma Homocysteine Level Is an Independent Predictor of Coronary Heart Disease Events in Patients with Type.
Antibiotic-Induced Changes in the Intestinal Microbiota and Disease Simone Becattini, Ying Taur, Eric G. Pamer Trends in Molecular Medicine Volume 22,
Date of download: 6/29/2016 Copyright © The American College of Cardiology. All rights reserved. From: The metabolic syndrome, diabetes, and subclinicalatherosclerosis.
Evaluation and treatment of coronary artery disease in patients with end-stage renal disease Peter A. McCullough Kidney International Volume 67, Pages.
Colloquium on Therapy of Right Heart Failure
Volume 353, Issue 9155, Pages (March 1999)
Volume 43, Issue 10, Pages (October 2012)
Volume 11, Issue 2, Pages (June 2016)
Volume 11, Issue 2, Pages (June 2016)
High and increasing prevalence of inflammatory bowel disease in Finland with a clear North–South difference  Airi Jussila, Lauri J. Virta, Veikko Salomaa,
Volume 385, Issue 9985, Pages (June 2015)
Volume 56, Issue 1, Pages (July 1969)
Volume 11, Issue 2, Pages (June 2016)
Volume 11, Issue 2, Pages (June 2016)
Ann Intern Med. 2000;133(6): doi: / Figure Legend:
Obesity and its Relation With Diabetes and Hypertension
The obesity paradox in men with coronary heart disease and heart failure: The role of muscle mass and leptin  S. Goya Wannamethee, A. Gerald Shaper, Peter.
Volume 11, Issue 2, Pages (June 2016)
Meta-Analysis of Dietary Glycemic Load and Glycemic Index in Relation to Risk of Coronary Heart Disease  Jia-Yi Dong, BSc, Yong-Hong Zhang, MD, PhD, Peiyu.
High and increasing prevalence of inflammatory bowel disease in Finland with a clear North–South difference  Airi Jussila, Lauri J. Virta, Veikko Salomaa,
Trends in Coronary Heart Disease Epidemiology in India
Long-term effects of hormone replacement therapy
Continuous 15-Year Decrease in Incidence and Mortality of Stroke in Finland by Juhani Sivenius, Jaakko Tuomilehto, Pirjo Immonen-Räihä, Minna Kaarisalo,
Trends in Fatal and Nonfatal Strokes Among Persons Aged 35 to ≥85 Years During 1991–2002 in Finland by Pia Pajunen, Rauni Pääkkönen, Helena Hämäläinen,
Relationship of Physical Activity and Body Mass Index to the Risk of Hypertension: A Prospective Study in Finland by Gang Hu, Noël C. Barengo, Jaakko Tuomilehto,
Global Trends in Pancreatic Cancer Mortality From 1980 Through 2013 and Predictions for 2017  Aimee L. Lucas, Matteo Malvezzi, Greta Carioli, Eva Negri,
Risk of coronary heart disease and risk of stroke in women with polycystic ovary syndrome: A systematic review and meta-analysis  Sarah A. Anderson, John.
Cardiovascular disease, chronic kidney disease, and diabetes mortality burden of cardiometabolic risk factors from 1980 to 2010: a comparative risk assessment 
Sunjoo Boo, RN, PhD, Erika Sivarajan Froelicher, RN, PhD, FAAN 
Low platelet counts predict mortality in severe community acquired pneumonia in children under 5 years of age: A hospital based observational study  Anubha.
Effects of Self-care Health Behaviors on Quality of Life Mediated by Cardiovascular Risk Factors Among Individuals with Coronary Artery Disease: A Structural.
Long-term effects of hormone replacement therapy
Cardiorespiratory Fitness: An Independent and Additive Marker of Risk Stratification and Health Outcomes  Barry A. Franklin, PhD, Peter A. McCullough,
Women's hearts are hard to break
How to evaluate and predict the ecologic impact of antibiotics: the pharmaceutical industry view from research and development  R. Bax  Clinical Microbiology.
Drug therapy for coronary heart disease: the Sheffield table
Myth of the menopause paradox
The surgical and interventional hybrid era: Experiences from China
Risk for Coronary Heart Disease Increases Risk for Colorectal Neoplasm
SNPs and coronary heart disease – Authors' reply
Diet-heart issues in a pharmacological era
Nat. Rev. Cardiol. doi: /nrcardio
Smoking and cardiovascular outcomes in dialysis patients: The United States Renal Data System Wave 2 Study1,2  Robert N. Foley, Charles A. Herzog, Allan.
Subclinical Hypothyroidism and the Risk of Coronary Heart Disease: A Meta-Analysis  Nicolas Rodondi, MD, MAS, Drahomir Aujesky, MD, MS, Eric Vittinghoff,
Volume 352, Pages S15-S18 (October 1998)
Normative scores on the Berg Balance Scale decline after age 70 years in healthy community-dwelling people: a systematic review  Stephen Downs, Jodie.
Cardiovascular Disease in Women of Reproductive Age
David M Nathan, MD, James Meigs, MPH, Daniel E Singer, MD  The Lancet 
Volume 385, Issue 9985, Pages (June 2015)
On Statin Treatment to Prevent Sepsis in Dialysis Patients
Study of Heart and Renal Protection (SHARP)
Amnon Sonnenberg  Clinical Gastroenterology and Hepatology 
Time Trends of Ulcer Mortality in Europe
Risks for Cardiovascular and Cardiac Deaths in Nonobese Patients With Diabetes and Coronary Heart Disease  Tetsuro Tsujimoto, MD, PhD, Hiroshi Kajio,
Anemia as a risk factor for cardiovascular disease
Low-technology approaches
Volume 73, Issue 12, Pages (June 2008)
American Journal of Kidney Diseases
Volume 150, Issue 7, Pages (June 2016)
Volume 383, Issue 9921, Pages (March 2014)
Volume 17, Issue 2, Pages (February 1950)
Björn Lindkvist, Stefan Appelros, Jonas Manjer, Anders Borgström 
Age-specific mortality rates from CHD and stroke in women and men in 2010 in selected countries. Age-specific mortality rates from CHD and stroke in women.
Estrogen and progestogen therapy in postmenopausal women
Sex Differences in Lifespan
Volume 2, Issue 6, Pages (June 2017)
Secular trends in cardiovascular disease mortality, incidence, and case fatality rates in adults in the United States  Ahmet Ergin, MD, PhD, MPH, Paul.
Presentation transcript:

Volume 11, Issue 2, Pages 207-212 (June 2016) 40-Year CHD Mortality Trends and the Role of Risk Factors in Mortality Decline  Pekka Jousilahti, Tiina Laatikainen, Veikko Salomaa, Arto Pietilä, Erkki Vartiainen, Pekka Puska  Global Heart  Volume 11, Issue 2, Pages 207-212 (June 2016) DOI: 10.1016/j.gheart.2016.04.004 Copyright © 2016 World Heart Federation (Geneva) Terms and Conditions

Figure 1 Age-standardized CHD mortality from 1969 to 2012 in Eastern Finland, men and women 35 to 64 years (per 100,000, logarithmic scale). CHD, coronary heart disease. Global Heart 2016 11, 207-212DOI: (10.1016/j.gheart.2016.04.004) Copyright © 2016 World Heart Federation (Geneva) Terms and Conditions

Figure 2 Predicted and observed reduction in CHD mortality from 1972 to 2012 in Eastern Finland, men 35 to 64 years. CHD, coronary heart disease. Global Heart 2016 11, 207-212DOI: (10.1016/j.gheart.2016.04.004) Copyright © 2016 World Heart Federation (Geneva) Terms and Conditions

Figure 3 Predicted and observed reduction in CHD mortality from 1972 to 2012 in Eastern Finland, women 35 to 64 years. CHD, coronary heart disease. Global Heart 2016 11, 207-212DOI: (10.1016/j.gheart.2016.04.004) Copyright © 2016 World Heart Federation (Geneva) Terms and Conditions

Figure 4 Age-standardized CHD mortality from 1973 to 2013 in Eastern and Southwestern Finland, men 35 to 74 years. CHD, coronary heart disease. Global Heart 2016 11, 207-212DOI: (10.1016/j.gheart.2016.04.004) Copyright © 2016 World Heart Federation (Geneva) Terms and Conditions

Figure 5 Age-standardized CHD mortality from 1973 to 2013 in Eastern and Southwestern Finland, women 35 to 74 years. CHD, coronary heart disease. Global Heart 2016 11, 207-212DOI: (10.1016/j.gheart.2016.04.004) Copyright © 2016 World Heart Federation (Geneva) Terms and Conditions